142 related articles for article (PubMed ID: 7870394)
1. 99Tcm-cystine, a renal function and imaging agent: a comparative study in dog with 131I-hippurate and 99Tcm-glucoheptonate to evaluate its functional and imaging characteristics.
Misra M; Sarkar HS; Chakravarty M; Sanyal S; Ganguly S; Sarkar BR; Chatterjee J; Dobe P; Ghosh S; Banerjee S
Nucl Med Commun; 1994 Nov; 15(11):878-85. PubMed ID: 7870394
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 99Tcm-bicisate as a renal imaging agent.
Ozker K; Kabasakal L; Liu Y; Hellman RS; Isitman A; Krasnow AZ; Collier BD
Nucl Med Commun; 1997 Aug; 18(8):771-5. PubMed ID: 9293508
[TBL] [Abstract][Full Text] [Related]
3. Clearance and renal extraction of technetium-99m-L,L-ethylenedicysteine, I-131-ortho-iodohippurate and I-125-iothalamate in pigs.
Nielsen SS; Poulsen EU; Marqversen J; Nielsen LE; Bacher T; Rehling M
Clin Physiol; 1999 Jul; 19(4):338-43. PubMed ID: 10451795
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of 99Tcm-MAG3 clearance in normal volunteers with the two-sample method: comparison with 131I-OIH.
Kanazawa T; Shimizu M; Seto H; Kageyama M; Kameda K; Toyoshima S; Tomizawa G; Watanabe N; Inagaki S
Nucl Med Commun; 1998 Sep; 19(9):899-903. PubMed ID: 10581597
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 99Tcm-N,N'-ethylene-1-dicysteine complex for dynamic kidney investigations.
Surma MJ; Wiewióra J; Liniecki J
Nucl Med Commun; 1994 Aug; 15(8):628-35. PubMed ID: 7970444
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 Apr; 19(4):314-20. PubMed ID: 8004863
[TBL] [Abstract][Full Text] [Related]
7. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-p-aminohippuric acid as a new renal agent.
Djokić D; Janković D; Maksin T; Jaksić E; Beatović S; Han R
Nucl Med Commun; 1999 Dec; 20(12):1133-40. PubMed ID: 10664994
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 May; 19(5):446-51. PubMed ID: 8039322
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the kinetics of the renal tracers 99Tcm-MAG3 and 131I-hippuran.
Pavía J; Ros D; Piera C; Pavía A; Bassa P; Giralt E; Setoain J
Nucl Med Commun; 1991 Jun; 12(6):529-37. PubMed ID: 1830943
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
12. 99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease.
Taylor AT; Lipowska M; Cai H
J Nucl Med; 2013 Apr; 54(4):578-84. PubMed ID: 23424193
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of renal scintigraphy with 99Tcm-mercaptoacetyltriglycine and 123I-orthoiodohippurate.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Furudate M
Nucl Med Commun; 1993 Aug; 14(8):644-52. PubMed ID: 8371889
[TBL] [Abstract][Full Text] [Related]
15. Comparison of scintigraphic renal differentials using radiolabeled orthoiodohippurate and glucoheptonate.
Jacobson AF; Matsuoka DT; Ferency GF; Miura RS; Avrin SA
Clin Nucl Med; 1991 Jun; 16(6):389-93. PubMed ID: 1868647
[TBL] [Abstract][Full Text] [Related]
16. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of renal concentration of technetium-99m glucoheptonate.
Lee HB; Blaufox MD
J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
[TBL] [Abstract][Full Text] [Related]
18. The effect of captopril on glucoheptonate uptake in experimental renal artery stenosis.
Gale B; Zhang C; Lee HB; Heller S; Blaufox MD
Nucl Med Commun; 1992 Feb; 13(2):110-3. PubMed ID: 1436896
[TBL] [Abstract][Full Text] [Related]
19. Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH.
Stadalnik RC; Vogel JM; Jansholt AL; Krohn KA; Matolo NM; Lagunas-Solar MC; Zielinski FW
J Nucl Med; 1980 Feb; 21(2):168-70. PubMed ID: 7356755
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment.
Misra M; Pradhan PK; De K; Chandra S; Das BK
Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]